A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Shanghai Junshi Bioscience Co., Ltd.
UNICANCER
Jules Bordet Institute
OHSU Knight Cancer Institute
University of Michigan Rogel Cancer Center
Hoag Memorial Hospital Presbyterian